An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... New Human 'Multi-Zonal' Liver Organoids Improve Injury Survival in Rodents Apr. 16 ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S.

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.